The role of liver transplantation in urea cycle disorders

Molecular Genetics and Metabolism

Volumn 81, Issue SUPPL., 2004, Pages 74-78

  Leonard, James V ^a   McKiernan, Peter J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; DISEASE SEVERITY; GRAFT FAILURE; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; METABOLIC DISORDER; MORBIDITY; NEPHROTOXICITY; ORGAN DONOR; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; UREA CYCLE; UREA CYCLE DISORDER; VIRUS INFECTION;

EID: 1642506318     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.08.027     Document Type: Article

References (34)

1. Surtees J.R., Leonard J.V. Acute metabolic encephalopathy: a review of causes, mechanisms and treatment. J. Inherit. Metab. Dis. 12(Suppl 1):1989;42-54.
2. Batshaw M.L., Roan Y., Yung A.L., Rosenberg L.A., Brusilow S.W. Cerebral dysfunction in asymptomatic carriers of ornithine carbamyl transferase deficiency. N. Engl. J. Med. 302:1980;482-485.
3. Nicolaides P., Liebsch D., Dale N., Leonard J., Surtees R. The neurological outcome of patients with ornithine carbamoyltransferase deficiency. Arch. Dis. Child. 86:2002;54-56.
4. Brusilow S., Horwich A.L. Urea cycle enzymes. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases Of Inherited Disease. eighth ed. 2001;1909-1964 McGraw Hill, New York.
5. Bachmann C. Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur. J. Pediatr. 162:2003;410-416.
6. Zimmermann A., Bachmann C., Baumgartner R. Severe liver fibrosis in argininosuccinic aciduria. Arch. Pathol. Lab. Med. 110:1986;136-140.
7. Scaglia F., Zheng Q., O'Brien W.E., Henry J., Rosenberger J., Reeds P., Lee B. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency. Pediatrics. 109:2002;150-152.
8. Jain A., Mazariegos G., Kashyap R., Kosmach-Park B., Starzl T.E., Fung J., Reyes J. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 73:2002;941-947.
9. Otte J.B. History of pediatric liver transplantation. Where are we coming from? Where do we stand? Pediatr. Transplant. 6:2002;378-387.
10. Van Mourik I.D., Beath S.V., Brook G.A., Cash A.J., Mayer A.D., Buckels J.A., Kelly D.A. Long-term nutritional and neurodevelopmental outcome of liver transplantation in infants aged less than 12 months. J. Pediatr. Gastroenterol. 30:2000;269-275.
11. Kayler L.K., Merion R.M., Lee S., Sung R.S., Punch J.D., Rudich S.M., Turcotte J.G., Campbell D.A.J., Holmes R., Magee J.C. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr. Transplant. 6:2002;295-300.
12. Ban K., Sugiyama N., Sugiyama K., Wada Y., Suzuki T., Hashimoto T., Kobayashi K. A pediatric patient with classical citrullinemia who underwent living-related partial liver transplantation. Transplantation. 71:2001;1495-1497.
13. Broelsch C.E., Emond J.C., Whitington P.F., Thistlethwaite J.R., Baker A.L., Lichtor J.L. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann. Surg. 212:1990;368-375.
14. Busuttil A.A., Goss J.A., Seu P., Dulkanchainun T.S., Yanni G.S., McDiarmid S.V., Busuttil R.W. The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency. Liver Transpl. Surg. 4:1998;350-354.
15. Fletcher J.M., Couper R., Moore D., Coxon R., Dorney S. Liver transplantation for citrullinaemia improves intellectual function. J. Inherit. Metab. Dis. 22:1999;581-586.
16. Hasegawa T., Tzakis A.G., Todo S., Reyes J., Nour B., Finegold D.N., Starzl T.E. Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J. Pediatr. Surg. 30:1995;863-865.
17. Ikeda S., Yazaki M., Takei Y., Ikegami T., Hashikura Y., Kawasaki S., Iwai M., Kobayashi K., Saheki T. Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation. J. Neurol. Neurosurg. Psychiatry. 71:2001;663-670.
18. Kiuchi T., Edamoto Y., Kaibori M., Uryuhara K., Kasahara M., Uemoto S., Egawa H., Inomata Y., Tanaka K. Auxiliary liver transplantation for urea-cycle enzyme deficiencies: lessons from three cases. Transplant. Proc. 31:1999;528-529.
19. Largilliere C., Houssin D., Gottrand F., Mathey C., Checoury A., Alagille D., Farriaux J.P. Liver transplantation for ornithine transcarbamylase deficiency in a girl. J. Pediatr. 115:1989;415-417.
20. Nagasaka H., Yorifuji T., Egawa H., Kikuta H., Tanaka K., Kobayashi K. Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency. J. Pediatr. 138:2001;432-434.
21. Santos S.E., Martins E., Cardoso M.L., Barbot C., Vilarinho L., Medina M. Liver transplantation in a case of argininaemia. J. Inherit. Metab. Dis. 24:2001;885-887.
22. Saudubray J.M., Touati G., Delonlay P., Jouvet P., Narcy C., Laurent J., Rabier D., Kamoun P., Jan D., Revillon Y. Liver transplantation in urea cycle disorders. Eur. J. Pediatr. 158(Suppl 2):1999;S55-S59.
23. Takanashi J., Kurihara A., Tomita M., Kanazawa M., Yamamoto S., Morita F., Ikehira H., Tanada S., Kohno Y. Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency. Neurology. 59:2002;210-214.
24. Todo S., Starzl T.E., Tzakis A., Benkov K.J., Kalousek F., Saheki T., Tanikawa K., Fenton W.A. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology. 15:1992;419-422.
25. Tuchman M. Persistent acitrullinemia after liver transplantation for carbamylphosphate synthetase deficiency. N. Engl. J. Med. 320:1989;1498-1499.
26. Uemoto S., Yabe S., Inomata Y., Nishizawa H., Asonuma K., Egawa H., Kiuchi T., Okajima H., Yamaoka Y., Yamabe H., Inui A., Fujisawa T., Tanaka K. Coexistence of a graft with the preserved native liver in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency. Transplantation. 63:1997;1026-1028.
27. Whitington P.F., Alonso E.M., Boyle J.T., Molleston J.P., Rosenthal P., Emond J.C., Millis J.M. Liver transplantation for the treatment of urea cycle disorders. J. Inherit. Metab. Dis. 21(Suppl 1):1998;112-118.
28. Noujaim H.M., Mayer D.A., Buckles J.A., Beath S.V., Kelly D.A., Mckiernan P.J., Mirza D.F., De Ville D. Techniques for and outcome of liver transplantation in neonates and infants weighing up to 5. kg J. Pediatr. Surg. 37:2002;159-164.
29. Plochl W., Plochl E., Pokorny H., Kozek-Langenecker S., Zacherl J., Stockler-Ipsiroglu S., Wermuth B., Spiss C.K., Muhlbacher F. Multiorgan donation from a donor with unrecognized ornithine transcarbamylase deficiency. Transpl. Int. 14:2001;196-201.
30. McDiarmid S.V., Millis M.J., Olthoff K.M., So S.K. Indications for pediatric liver transplantation. Pediatr. Transplant. 2:1998;106-116.
31. Lee B., Goss J. Long-term correction of urea cycle disorders. J. Pediatr. 138(Suppl 1):2001;S62-S71.
32. Raper S.E., Yudcoff M., Chirmule N., Gao G.P., Nunes F., Haskal Z.J., Furth E.E., Propert K.J., Robinson M.B., Magosin S., Simoes H., Speicher L., Hughes J., Tazelaar J., Wivel N.A., Wilson J.M., Batshaw M.L. A pilot study of in vivo liver directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum. Gene Ther. 13:2002;163-175.
33. Lee B., Dennis J.A., Healy P.J., Mull B., Pastore L., Yu H., Aguilar-Cordova E., O'Brien W., Reeds P., Beaudet A.L. Hepatocyte gene therapy in a large animal: neonatal bovine model of citrullinaemia. Proc. Natl. Acad. Sci. USA. 96:1999;3981-3986.
34. Horslen S.P., McCowan T.C., Goertzen T.C., Warkentin P.I., Cai H.B., Strom S.C., Fox I.J. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics. 111:2003;1262-1267.